Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Amicus Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 222
- +12 vs. Q2 2022
- Shares held
- 292.4M
- −12.8M (−4.2%) vs. Q2 2022
- Total value
- $3.05B
- −$229.0M (−7.0%) vs. Q2 2022
- New holders
- 34
- 73 more added
- Sold out
- 22
- 72 more reduced
3 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $11.5K |
| Q1 2026 | 298 | $4.81B |
| Q4 2025 | 332 | $4.57B |
| Q3 2025 | 287 | $2.46B |
| Q2 2025 | 272 | $1.83B |
| Q1 2025 | 286 | $2.55B |
| Q4 2024 | 290 | $2.88B |
| Q3 2024 | 293 | $3.31B |
| Q2 2024 | 259 | $3.13B |
| Q1 2024 | 254 | $3.79B |
| Q4 2023 | 229 | $4.53B |
| Q3 2023 | 229 | $3.63B |
| Q2 2023 | 216 | $3.86B |
| Q1 2023 | 226 | $3.30B |
| Q4 2022 | 230 | $3.57B |
| Q3 2022 | 222 | $3.05B |
| Q2 2022 | 213 | $3.28B |
| Q1 2022 | 216 | $2.87B |
| Q4 2021 | 224 | $3.48B |
| Q3 2021 | 238 | $2.80B |
| Q2 2021 | 235 | $2.67B |
| Q1 2021 | 259 | $2.74B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 2,325,000 | $24.3M | 1.37% | 00.0% | Unchanged |
| Healthcare of Ontario Pension Plan Trust Fund | 2,626,600 | $27.4M | 0.14% | +884,400+50.8% | Added |
| Northern Trust Corp | 2,663,688 | $27.8M | 0.01% | −30,413−1.1% | Reduced |
| FMR LLC | 2,794,068 | $29.2M | 0.00% | +744,451+36.3% | Added |
| D. E. Shaw & Co., Inc. | 2,903,496 | $30.3M | 0.05% | −65,240−2.2% | Reduced |
| Pictet Asset Management SA | 3,485,302 | $36.4M | 0.05% | +2,842,220+442.0% | Added |
| Fiera Capital Corp | 4,016,555 | $38.1M | 0.14% | −66,317−1.6% | Reduced |
| Artal Group S.A. | 4,000,000 | $41.8M | 2.18% | 00.0% | Unchanged |
| Norges Bank | 4,356,740 | $45.5M | 0.01% | +1,511,838+53.1% | Added |
| Geode Capital Management, LLC | 4,722,886 | $49.3M | 0.01% | +63,632+1.4% | Added |
| Macquarie Group Ltd | 6,877,761 | $71.8M | 0.09% | +110,515+1.6% | Added |
| Wellington Management Group LLP | 8,056,375 | $84.1M | 0.02% | −2,968,369−26.9% | Reduced |
| Palo Alto Investors LP | 9,847,774 | $102.8M | 8.13% | 00.0% | Unchanged |
| State Street Corp | 12,022,212 | $125.5M | 0.01% | −1,896,103−13.6% | Reduced |
| JPMorgan Chase & Co | 14,337,705 | $149.7M | 0.02% | −1,526,402−9.6% | Reduced |
| Janus Henderson Group PLC | 14,776,115 | $154.3M | 0.12% | −2,004,026−11.9% | Reduced |
| Morgan Stanley | 17,183,513 | $179.4M | 0.02% | −1,130,067−6.2% | Reduced |
| BlackRock Inc. | 19,898,552 | $207.7M | 0.01% | −351,306−1.7% | Reduced |
| Redmile Group, LLC | 21,719,191 | $226.7M | 8.80% | −439,700−2.0% | Reduced |
| Vanguard Group Inc | 25,871,062 | $270.1M | 0.01% | +138,973+0.5% | Added |
| Avoro Capital Advisors LLC | 26,800,000 | $279.8M | 5.17% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 27,372,917 | $285.8M | 8.31% | +477,385+1.8% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −848,157−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −753,037−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −478,245−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −110,652−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −65,788−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −49,340−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −47,952−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −34,639−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −32,199−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −27,077−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −26,399−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,023−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −11,561−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −1,205−100.0% | Sold out |
| Antonetti Capital Management LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −248−100.0% | Sold out |
| Moisand Fitzgerald Tamayo, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −1,017−100.0% | Sold out |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |
| Cordasco Financial Network | – | – | – | – | Not filed |
| Exane Derivatives | – | – | – | – | Not filed |